Correlation Between Sentry Petroleum and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Sentry Petroleum and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sentry Petroleum and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sentry Petroleum and Neurocrine Biosciences, you can compare the effects of market volatilities on Sentry Petroleum and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sentry Petroleum with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sentry Petroleum and Neurocrine Biosciences.

Diversification Opportunities for Sentry Petroleum and Neurocrine Biosciences

0.0

Correlation Coefficient

Sentry Petroleum  Neurocrine Biosciences

Pay attention - limited upside

The 3 months correlation between Sentry and Neurocrine is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sentry Petroleum and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Sentry Petroleum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sentry Petroleum are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Sentry Petroleum i.e., Sentry Petroleum and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Sentry Petroleum and Neurocrine Biosciences

If you would invest  12,231  in Neurocrine Biosciences on September 17, 2024 and sell it today you would earn a total of  1,077  from holding Neurocrine Biosciences or generate 8.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Sentry Petroleum  vs.  Neurocrine Biosciences

Sentry Petroleum

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sentry Petroleum has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Sentry Petroleum is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Neurocrine Biosciences

Risk-Adjusted Performance

6 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Sentry Petroleum and Neurocrine Biosciences

The main advantage of trading using opposite Sentry Petroleum and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sentry Petroleum position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Sentry Petroleum and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.